DNA testing. Genetic screen misses mutations in women at high risk of breast cancer

Erik Stokstad. Science. 2006.

. 2006 Mar 31;311(5769):1847.

doi: 10.1126/science.311.5769.1847a.

No abstract available

Similar articles

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA, Wilson JE. Wolff TA, et al. Am Fam Physician. 2006 Nov 15;74(10):1759-60. Am Fam Physician. 2006. PMID: 17137007 Review. No abstract available.
Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
Hartikainen JM, Kataja V, Pirskanen M, Arffman A, Ristonmaa U, Vahteristo P, Ryynänen M, Heinonen S, Kosma VM, Mannermaa A. Hartikainen JM, et al. Clin Genet. 2007 Oct;72(4):311-20. doi: 10.1111/j.1399-0004.2007.00866.x. Clin Genet. 2007. PMID: 17850627
Mutations of BRCA genes in hereditary breast and ovarian cancer.
Radice P. Radice P. J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):9-12. J Exp Clin Cancer Res. 2002. PMID: 12585647 Review.
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
Spannuth WA, Thaker PH, Sood AK. Spannuth WA, et al. Am J Obstet Gynecol. 2007 Apr;196(4):e6-9. doi: 10.1016/j.ajog.2007.01.026. Am J Obstet Gynecol. 2007. PMID: 17403394
Optimal selection of individuals for BRCA mutation testing.
Evans DG, Lalloo F, Eccles D. Evans DG, et al. J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. doi: 10.1200/JCO.2006.06.6134. J Clin Oncol. 2006. PMID: 16829657 No abstract available.